Information  X 
Enter a valid email address

EPIC/TIDM matching '0QSS'

Date
Time Source
Company
Announcement
14 Dec 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer
10 Dec 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present at the JMP Securities Hematology Summit
07 Dec 2020 7:00 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting
03 Dec 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting
12 Nov 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present at Jefferies Virtual Healthcare Conference
05 Nov 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2020
  7:00 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Selected for Oral Presentation at the American Society of Hematology 2020 Annual Meeting
04 Nov 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2020.
02 Nov 2020 8:19 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government
29 Oct 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2020
26 Oct 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Appoints Stewart Craig as Chief Technical Officer
12 Oct 2020 10:51 am GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital - September 30, 2020
21 Sep 2020 9:45 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
  9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen
16 Sep 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update
14 Sep 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment
  5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2020
06 Aug 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2020
10 Jul 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2020
26 Jun 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Reports Voting Results from its Annual General Meeting Held on June 26, 2020
25 Jun 2020 7:00 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH extends its cash horizon by implementing a convertible bond financing
09 Jun 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – May 30, 2020
  6:30 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Update on Phase 2 Investigator Sponsored Trial of Eryaspase in Second-Line Acute Lymphoblastic Leukemia
02 Jun 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Participate Fireside Chat at Jefferies Virtual Healthcare Conference
01 Jun 2020 6:30 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting
07 May 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2020
06 May 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Cash Balance at End of Q1 2020
05 May 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH engages in collaborative partnership with EU Horizon 2020 EVIDENCE consortium
30 Apr 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host on May 7, 2020 First Quarter Conference Call and Business Update
28 Apr 2020 11:13 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer
  9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer
20 Apr 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer
06 Apr 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2020
19 Mar 2020 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F
16 Mar 2020 10:05 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2019
  6:30 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces the Appointment of Dr. Melanie Rolli to its Board of Directors
12 Mar 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host Fourth Quarter and Full Year 2019 Conference Call and Business Update
06 Mar 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – February 29, 2020
26 Feb 2020 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present at Cowen and Company 40th Annual Health Care Conference
20 Feb 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Enters Into Strategic Supply Partnership with the German Red Cross Blood Donor Service
04 Feb 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2020
24 Jan 2020 6:30 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces a Poster Presentation for TRYbeCA1 at the ASCO 2020
10 Jan 2020 4:45 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2019
02 Dec 2019 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2019
25 Nov 2019 6:30 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer
14 Nov 2019 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present at Jefferies 2019 Healthcare Conference in London
07 Nov 2019 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2019
05 Nov 2019 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host Third Quarter 2019 Conference Call and Business Update on November 8, 2019
  5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2019
04 Nov 2019 6:30 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Achieves Milestones in TRYbeCA1 Phase 3 Trial of Eryaspase in Second-line Pancreatic Cancer
04 Oct 2019 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2019
17 Sep 2019 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2019
11 Sep 2019 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host Second Quarter 2019 Conference Call and Business Update
03 Sep 2019 4:51 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2019
02 Aug 2019 4:45 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2019
16 Jul 2019 9:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 21, 2019
02 Jul 2019 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2019
26 Jun 2019 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC
24 Jun 2019 10:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies


Company Announcements Archive »


a d v e r t i s e m e n t